These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2970288)

  • 21. Severe circumscribed cortical atrophy in Huntington's disease.
    Garrett WT; Brashear HR; Cail WS; Lovell MA; Clayton MT; Harrison MB
    Neurology; 1998 Aug; 51(2):638-9. PubMed ID: 9710061
    [No Abstract]   [Full Text] [Related]  

  • 22. Bicaudate diameter--the most specific and simple CT parameter in the diagnosis of Huntington's disease.
    Stober T; Wussow W; Schimrigk K
    Neuroradiology; 1984; 26(1):25-8. PubMed ID: 6234475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Computer-tomographic studies of the brain in neurology (5-year experience with our own studies and short review of the foreign literature)].
    Vereshchagin NV; Vavilov SB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(9):1402-11. PubMed ID: 6227175
    [No Abstract]   [Full Text] [Related]  

  • 24. Iodine-123-IBZM dopamine D2 receptor and technetium-99m-HMPAO brain perfusion SPECT in the evaluation of patients with and subjects at risk for Huntington's disease.
    Ichise M; Toyama H; Fornazzari L; Ballinger JR; Kirsh JC
    J Nucl Med; 1993 Aug; 34(8):1274-81. PubMed ID: 8326384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Review of the system of positron emission tomography and its clinical application].
    Tateno Y; Shishido F
    No To Shinkei; 1982 Sep; 34(9):827-43. PubMed ID: 6215930
    [No Abstract]   [Full Text] [Related]  

  • 26. A comparison of neurological, metabolic, structural, and genetic evaluations in persons at risk for Huntington's disease.
    Grafton ST; Mazziotta JC; Pahl JJ; St George-Hyslop P; Haines JL; Gusella J; Hoffman JM; Baxter LR; Phelps ME
    Ann Neurol; 1990 Nov; 28(5):614-21. PubMed ID: 1979723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single photon emission computed tomography in subjects at risk for Huntington's chorea.
    Leblhuber F; Brucker B; Reisecker F; Steinparz F; Windhager E; Trenkler J; Deisenhammer E
    J Neurol; 1990 Dec; 237(8):496-8. PubMed ID: 2150077
    [No Abstract]   [Full Text] [Related]  

  • 28. [Direct genetic diagnosis in Huntington's chorea].
    Spiegel R; Weigell-Weber M; Hergersberg M; Schmid W
    Schweiz Med Wochenschr; 1993 Dec; 123(48):2271-7. PubMed ID: 8272801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. When is it not Huntington's disease?
    Heckmann JM; Bryer A; Greenberg LJ
    S Afr Med J; 2001 Feb; 91(2):132-3. PubMed ID: 11288392
    [No Abstract]   [Full Text] [Related]  

  • 30. [SPECT studies with 99mTc-HMPAO in Huntington's chorea patients].
    Botsch H; Oepen G; Deuschl G; Wolff G
    Rofo; 1987 Dec; 147(6):666-8. PubMed ID: 2827263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [PET imaging of dementia].
    Yokoi F; Ando K
    Nihon Rinsho; 1985 Jul; 43(7):1433-7. PubMed ID: 2932569
    [No Abstract]   [Full Text] [Related]  

  • 32. Repetitive belching, aerophagia, and torticollis in Huntington's disease: a case report.
    Hu MT; Chaudhuri KR
    Mov Disord; 1998 Mar; 13(2):363-5. PubMed ID: 9539359
    [No Abstract]   [Full Text] [Related]  

  • 33. Positron emission tomographic scan investigations of Huntington's disease: cerebral metabolic correlates of cognitive function.
    Berent S; Giordani B; Lehtinen S; Markel D; Penney JB; Buchtel HA; Starosta-Rubinstein S; Hichwa R; Young AB
    Ann Neurol; 1988 Jun; 23(6):541-6. PubMed ID: 2970247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computerized tomography in hereditary nonprogressive chorea.
    Rice E; Terrence C
    Arch Neurol; 1979 Apr; 36(4):249-50. PubMed ID: 154881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroimaging and dementia.
    Benson DF
    Neurol Clin; 1986 May; 4(2):341-53. PubMed ID: 2940453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Huntington's disease in a Coloured family.
    Saffer DS; Nathan DC; Kahle PA; Steingo B
    S Afr Med J; 1974 Nov; 48(58):2399-402. PubMed ID: 4279450
    [No Abstract]   [Full Text] [Related]  

  • 37. Thirteen years longitudinal study of computed tomography, visual electrophysiology and neuropsychological changes in Huntington's chorea patients and 50% at-risk asymptomatic subjects.
    Cala LA; Black JL; Collins DW; Ellison RM; Zubrick SA
    Clin Exp Neurol; 1990; 27():43-63. PubMed ID: 2151811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Single-photon emission-computed tomography in the differential diagnosis of dementia].
    Deisenhammer E; Reisecker F; Leblhuber F; Höll K; Markut H; Trenkler J; Schneider I
    Dtsch Med Wochenschr; 1989 Oct; 114(43):1639-44. PubMed ID: 2530079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebellar atrophy in Huntington's disease: clinical report and computerized tomography.
    Bianco F; Bozzao L; Rizzo PA; Morocutti C
    Acta Neurol (Napoli); 1981 Apr; 3(2):425-8. PubMed ID: 6458199
    [No Abstract]   [Full Text] [Related]  

  • 40. The use of technetium-99m-HM-PAO in the assessment of patients with dementia and other neuropsychiatric conditions.
    Smith FW; Besson JA; Gemmell HG; Sharp PF
    J Cereb Blood Flow Metab; 1988 Dec; 8(6):S116-22. PubMed ID: 2973469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.